10x Genomics Raises 2026 Revenue Outlook, Targets 50 Atera Shipments

10x Genomics raised its 2026 revenue outlook and lifted its year-end Atera shipment target to about 50 instruments, a quarter more than its previous goal. The new revenue range is $625 million to $635 million, compared with the previous $610 million to $630 million. Removing one-time licensing and royalty income from patent settlements in both years, the forecast implies 4% to 6% revenue growth in 2026. Third-quarter revenue was $150.7 million for the period ended Sept. 30, up 1% from $149 million a year earlier.

Source: TokenPost